(R)-2-[1-(2,6-Dichloro-3,4,5-trimeth-oxy-benzo-yl)pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide
- PMID: 21754243
- PMCID: PMC3099877
- DOI: 10.1107/S1600536811010270
(R)-2-[1-(2,6-Dichloro-3,4,5-trimeth-oxy-benzo-yl)pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide
Abstract
In the title compound, C(21)H(28)Cl(2)N(3)O(6), the nitronyl nitroxide ring displays a half-chair conformation, whereas the pyrrolidine ring has an envelope conformation. These two rings are twisted to each other with N-C-C-N torsion angles around the connecting C-C bond of 48.9 (6) and -127.0 (5)°. The benzene ring is nearly perpendicular to the pyrrolidine ring, with torsion angles around the connecting C-C bond of 86.3 (6) and -97.7 (6)°. The crystal structure is stabilized by C-H⋯O and C-H⋯π hydrogen bonds, which build up a three-dimensional network.
Figures
References
-
- Allen, F. H. (2002). Acta Cryst. B58, 380–388. - PubMed
-
- Bruker (2007). APEX2, SAINT and SADABS Bruker AXS Inc., Madison, Wisconsin, USA.
-
- Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
-
- Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354–1358.
-
- Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases